Juntendo University Hospital_Tokyo

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Chronic kidney disease1 trial
• IgA nephropathy1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Novo Nordisk A/S2 trials
• Novartis Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  Atrasentan in Patients With IgA Nephropathy

  NCT04573478· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

  NCT03819153· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

  NCT03914326· Phase 3· Novo Nordisk A/S· Source